Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.60p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 5,894,213
  • Market Cap: £349.21m
  • RiskGrade: 119
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
25.39% below the market average25.39% below the market average25.39% below the market average25.39% below the market average25.39% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
1yr Revenue Growth
27.42% below the market average27.42% below the market average27.42% below the market average27.42% below the market average27.42% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.88% below the market average4.88% below the market average4.88% below the market average4.88% below the market average4.88% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Book Ratio
36.33% below the market average36.33% below the market average36.33% below the market average36.33% below the market average36.33% below the market average
26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
28.12% below the market average28.12% below the market average28.12% below the market average28.12% below the market average28.12% below the market average
29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average
Price Chg 3m
51.78% above the market average51.78% above the market average51.78% above the market average51.78% above the market average51.78% above the market average
54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
54.89% above the market average54.89% above the market average54.89% above the market average54.89% above the market average54.89% above the market average
68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average
Momentum 20
25.89% below the market average25.89% below the market average25.89% below the market average25.89% below the market average25.89% below the market average
Sector averageSector averageSector averageSector averageSector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
46.31% below the market average46.31% below the market average46.31% below the market average46.31% below the market average46.31% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
10.39% above the market average10.39% above the market average10.39% above the market average10.39% above the market average10.39% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average
Forecast EPS
64.64% below the market average64.64% below the market average64.64% below the market average64.64% below the market average64.64% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
37.70% above the market average37.70% above the market average37.70% above the market average37.70% above the market average37.70% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Operating Profit Loss
80.95% below the market average80.95% below the market average80.95% below the market average80.95% below the market average80.95% below the market average
41.67% below the sector average41.67% below the sector average41.67% below the sector average41.67% below the sector average41.67% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
40.89% above the market average40.89% above the market average40.89% above the market average40.89% above the market average40.89% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Cash
44.36% above the market average44.36% above the market average44.36% above the market average44.36% above the market average44.36% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
92.76% below the market average92.76% below the market average92.76% below the market average92.76% below the market average92.76% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Brokers Percent Neutral
80.43% above the market average80.43% above the market average80.43% above the market average80.43% above the market average80.43% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.60p
52 Week Low 29.35p
Volume 5,894,213
Shares Issued 540.57m
Market Cap £349.21m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth
49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 08-May-2025

Time Volume / Share Price
16:35 222,736 @ 64.60p
16:35 924 @ 64.60p
16:35 810 @ 64.60p
16:35 1,700 @ 64.60p
16:35 1,734 @ 64.60p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page